AGF Management Ltd. Purchases 2,535 Shares of Chemed Corporation $CHE

AGF Management Ltd. boosted its holdings in shares of Chemed Corporation (NYSE:CHE) by 50.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,529 shares of the company’s stock after buying an additional 2,535 shares during the quarter. AGF Management Ltd. owned approximately 0.05% of Chemed worth $3,371,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in CHE. Geneos Wealth Management Inc. grew its position in shares of Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after purchasing an additional 76 shares in the last quarter. DAVENPORT & Co LLC boosted its stake in Chemed by 10.2% during the second quarter. DAVENPORT & Co LLC now owns 474 shares of the company’s stock valued at $231,000 after buying an additional 44 shares during the last quarter. KLP Kapitalforvaltning AS grew its holdings in Chemed by 26.3% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 4,800 shares of the company’s stock valued at $2,337,000 after buying an additional 1,000 shares in the last quarter. Roundview Capital LLC increased its stake in Chemed by 2.4% in the 2nd quarter. Roundview Capital LLC now owns 2,072 shares of the company’s stock worth $1,009,000 after acquiring an additional 48 shares during the last quarter. Finally, Vontobel Holding Ltd. raised its holdings in shares of Chemed by 44.5% during the 2nd quarter. Vontobel Holding Ltd. now owns 2,821 shares of the company’s stock worth $1,374,000 after acquiring an additional 869 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $437.55, for a total transaction of $875,100.00. Following the completion of the transaction, the chief executive officer owned 94,197 shares of the company’s stock, valued at $41,215,897.35. This trade represents a 2.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 3.29% of the stock is owned by company insiders.

Chemed Stock Performance

Shares of NYSE CHE opened at $443.65 on Thursday. The firm has a market capitalization of $6.28 billion, a price-to-earnings ratio of 23.46, a PEG ratio of 2.11 and a beta of 0.44. The stock has a 50 day moving average price of $436.40 and a 200 day moving average price of $441.99. Chemed Corporation has a 52-week low of $408.42 and a 52-week high of $623.60.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 5th. Shareholders of record on Monday, November 17th were paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date was Monday, November 17th. Chemed’s payout ratio is presently 12.69%.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on CHE shares. Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Royal Bank Of Canada lowered their price target on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a report on Monday, November 10th. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $555.50.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.